Edgar Lederer
24Patents
11h-index
29Co-inventors
71Inventor score
Filing activity: Nov 17, 1972 → Nov 7, 1985
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4006261A | Flavoring with mixtures of theobromine and cyclic dipeptides | Chemistry; Metallurgy | 44 | Expired |
| US4235771A | Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents | Emerging Cross-Sectional Technologies | 34 | Expired |
| US4036953A | Process for preparing vaccine adjuvant | Emerging Cross-Sectional Technologies | 32 | Expired |
| US4185089A | Immunological adjuvant constituted by the p-amino-phenyl derivative of N-acetyl-muramyl-L-alanyl-D-isoglutamine | Human Necessities | 25 | Expired |
| US4153684A | Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives | Human Necessities | 22 | Expired |
| US4186194A | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents | Emerging Cross-Sectional Technologies | 16 | Expired |
| US4158052A | Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-isoglutamine | Human Necessities | 15 | Expired |
| US4396607A | Muramyl peptide derivatives and pharmaceutical compositions | Human Necessities | 13 | Expired |
| US3976544A | Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction | Emerging Cross-Sectional Technologies | 13 | Expired |
| US4427659A | Muramyl peptide substituted on a peptide nitrogen and medicaments containing the same | Human Necessities | 12 | Expired |
| US4152423A | Immunological agents | Human Necessities | 11 | Expired |
| US4461761A | Oligomers of compounds of the muramyl-peptide type and medicaments containing them | Chemistry; Metallurgy | 10 | Expired |
| US4101649A | Hydrosoluble agents having non specific immunodepressive properties | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4125603A | Stabilized water-in-oil emulsions and compositions | Human Necessities | 9 | Expired |
| US4042678A | Water-soluble agents having mitogenic properties obtained from nocardia cells, and processes for the preparation thereof | Emerging Cross-Sectional Technologies | 9 | Expired |
| US4220637A | Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents | Chemistry; Metallurgy | 9 | Expired |
| US4370265A | Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4272524A | N-Acyl-muramyl peptide derivatives having anti-infectious infections properties | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4401659A | Muramyl-peptides fixed to peptide-polymers and pharmaceutical compositions containing them | Emerging Cross-Sectional Technologies | 6 | Expired |
| US4172125A | Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-glutamic acid and method of use | Human Necessities | 5 | Expired |
| US4693998A | Novel compounds of the muramyl peptide | Human Necessities | 3 | Expired |
| US4201768A | Process for obtaining agents having mitogenic and/or adjuvant properties from Nocardia cells and compositions containing such agents | Human Necessities | 3 | Expired |
| US4698330A | Somnogenic compositions and method of use | Human Necessities | 2 | Expired |
| US4335111A | Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.